hCD3EDG/hBCMA/hCD20(2)
Nomenclature
C57BL/6JSmo-Tnfrsf17tm1(hBCMA)Cd3etm1(hCD3E)Cd3dtm1(hCD3D)Cd3gtm1(hCD3G)Ms4a1tm3(hCD20)Smoc
Cat. NO.
NM-XA-254204
Strain State
Developing
Model Description
The hCD3EDG/hBCMA (NM-XA-253164) was crossed with hCD20(2)(NM-HU-200114) to generate hCD3EDG/hBCMA/hCD20(2) mice.
*Literature published using this strain should indicate: hCD3EDG/hBCMA/hCD20(2) mice (Cat. NO. NM-XA-254204) were purchased from Shanghai Model Organisms Center, Inc..
You may also like
Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute
On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.
Learn more
Workshop：Progress and Advances in Preclinical immuno-Oncology Research
SMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.
Learn more
